Giant prolactinomas in men: efficacy of cabergoline treatment

Salvatore Maria Corsello, G Ubertini, M Altomare, Rm Lovicu, Mg Migneco, Carlo Antonio Rota, Cesare Colosimo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

95 Citazioni (Scopus)


The term 'giant prolactinoma' can be used for tumours larger than 4 cm in diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long-lasting dopamine agonist (DA), safe and well tolerated, is effective in normalizing PRL levels and inducing tumour shrinkage in micro- and macroprolactinomas. The purpose of this prospective study was to evaluate the efficacy and safety of CAB also for giant prolactinomas.
Lingua originaleEnglish
pagine (da-a)662-670
Numero di pagine9
RivistaClinical Endocrinology
Stato di pubblicazionePubblicato - 2003


  • Adrenal Glands
  • Adult
  • Aged
  • Antineoplastic Agents
  • Erectile Dysfunction
  • Ergolines
  • Humans
  • Hypothyroidism
  • Libido
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Pituitary Gland
  • Pituitary Neoplasms
  • Prolactin
  • Prolactinoma
  • Vision Disorders


Entra nei temi di ricerca di 'Giant prolactinomas in men: efficacy of cabergoline treatment'. Insieme formano una fingerprint unica.

Cita questo